Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) showing dropped of -8.17% and closed at $2.36, after gaining total volume of 600,643.00 shares. Its earnings per share (EPS) is $0.00 and its beta value stands at -4.52 points and has total market capitalization of $252.61 million and a total of 114.12 million outstanding shares.
Cannabics Pharmaceuticals Inc (CNBX) on February 6, 2017 announced it will begin providing personalized cannabinoid anti-tumor tests for cancer patients. The diagnostic tests are based on liquid biopsies of patients suffering from any kind of cancer. The test uses CTC technology that collects cancer cells from patients’ blood samples, and tests their sensitivity to cannabinoid compounds alongside conventional chemotherapy medicine.
The results enable doctors to make better informed decisions by providing personalized patient data as supporting evidence to available medical treatments. Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals said, “Our vision is to embrace the natural medicinal properties of cannabis utilizing the diversity of active compounds to fight cancer in its manifestation in each individual patient”.
Through an exclusive collaboration with Cancer Hope Israel, which specializes in providing a comprehensive check of the effectiveness of chemotherapy and innovative biological medicines, Cannabics will provide its proprietary cannabinoid based compounds to be assessed in their anti-tumor properties.
Earth Science Tech Inc (OTCMKTS:ETST) reported the plunge of -3.85% and closed at $1.25, with the total traded volume of 39,714.00 shares. During last trade its minimum price was $1.14 and it gained its highest price of $1.31 and has a total of 40.91 million outstanding shares.
Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, sports, and alternative medicine worldwide. It focuses on non-prescription nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company also provides consulting services to the athletic facilities industry. Its marketing services include direct marketing, search engine optimization, public relations, email marketing, social media marketing, and development of referral programs. In addition, Earth Science Tech, Inc. retails health and wellness brands, as well as sports nutrition and dietary supplement products; and stocks and sells high grade cannabidiol rich hemp oil and products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in April 2014. The company was incorporated in 2010 and is headquartered in Boca Raton, Florida.
CV Sciences Inc (OTCMKTS:CVSI) increased 4.29% closed at $0.365 and traded with total volume of 232,555.00 shares, while the average trading remained 368,850.00 shares. During last trade its minimum price was $0.35 and it gained the highest price of $0.37. Its market capitalization was $22.90 billion.
CV Sciences Inc (CVSI) on March 13, 2017 announced the launch of the first online education platform designed to enhance its brand education and advocacy through Experticity. Currently over 750 consumer brands, including The North Face, Dyson, and Quiksilver, are working with Experticity to educate and tap into real-life experts (industry professionals, category opinion leaders, online influencers and passionate retail sales associates) to create a new breed of buying experience — one that is informed, genuine and mutually beneficial for retailers and consumers. CV Sciences’ education platform will cover a variety of topics pertaining to hemp, phytocannabinoids, and its industry-dominating consumer products brand, PlusCBD Oil.
A recent study by Experticity has shown that education-based trainings have proven effective at increasing sales, with Experticity members having 22.2 times more buying conversations each week that involve product recommendations than the average person. Eighty-two percent of those who received Experticity member recommendations also ended up purchasing products as a result.
“Investing in retailer education is a practice we know demonstrates results,” states Sarah Syed, Director of Marketing at CV Sciences. “CV Sciences is dedicated to supporting our retailer and wholesale partners by employing methods we know have a broad impact on consumer buying decisions.”